DUBLIN, April 12, 2021 /PRNewswire/ -- Cosmo Pharmaceuticals NV (SIX: COPN) today announced the FDA approval of GI Genius™ intelligent endoscopy system, its revolutionary device for lesion detection ...

Please provide your email address to receive an email when new articles are posted on . Medtronic recently received FDA de novo clearance for the GI Genius intelligence endoscopy module. GI Genius is ...

The GI Genius module uses advanced artificial intelligence to highlight the presence of pre-cancerous lesions with a visual marker in real-time – serving as an ever vigilant second observer. Studies ...

Vancouver, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The global medical endoscope devices market size was USD 29.1 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.1% during the forecast ...

NEW YORK--(BUSINESS WIRE)--Kips Bay Endoscopy Center (KBEC), a Covenant Physician Partner, will offer patients receiving a colonoscopy an enhanced screening with the aid of GI Genius™ intelligent ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced the OVMed® OCHTA camera module with quadruple the ...

OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog, and display technology, today announced the availability of several new OVMed ® ...

New York, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Gastrointestinal Endoscopy Market - A Global and Regional Analysis: Focus on Type, End User, and ...

Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Dublin, Ireland - 12 April 2021: Cosmo Pharmaceuticals NV (SIX: COPN) ...

Cosmo Pharmaceuticals NV (SIX: COPN) today announced the FDA approval of GI Genius(TM) intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The GI Genius ...